Pokorney, S., Hylek, E., Granger, C., Anstrom, K., Kline-Rogers, E. M., Alberts, M., … Naccarelli, G. (2018). PROVIDER- AND HOSPITAL-LEVEL VARIATION IN ORAL ANTICOAGULANT USE FOR STROKE PREVENTION IN ATRIAL FIBRILLATION. In Journal of the American College of Cardiology (Vol. 71, pp. A280–A280). Elsevier BV. https://doi.org/10.1016/s0735-1097(18)30821-0

Pokorney, Sean, Elaine Hylek, Christopher Granger, Kevin Anstrom, Eva M. Kline-Rogers, Mark Alberts, Peter Berger, et al. “PROVIDER- AND HOSPITAL-LEVEL VARIATION IN ORAL ANTICOAGULANT USE FOR STROKE PREVENTION IN ATRIAL FIBRILLATION.” In Journal of the American College of Cardiology, 71:A280–A280. Elsevier BV, 2018. https://doi.org/10.1016/s0735-1097(18)30821-0.

Pokorney S, Hylek E, Granger C, Anstrom K, Kline-Rogers EM, Alberts M, et al. PROVIDER- AND HOSPITAL-LEVEL VARIATION IN ORAL ANTICOAGULANT USE FOR STROKE PREVENTION IN ATRIAL FIBRILLATION. In: Journal of the American College of Cardiology. Elsevier BV; 2018. p. A280–A280.

Pokorney, Sean, et al. “PROVIDER- AND HOSPITAL-LEVEL VARIATION IN ORAL ANTICOAGULANT USE FOR STROKE PREVENTION IN ATRIAL FIBRILLATION.” Journal of the American College of Cardiology, vol. 71, no. 11, Elsevier BV, 2018, pp. A280–A280. Crossref, doi:10.1016/s0735-1097(18)30821-0.

Pokorney S, Hylek E, Granger C, Anstrom K, Kline-Rogers EM, Alberts M, Berger P, House J, Vijapurkar U, James R, Shah B, Naccarelli G. PROVIDER- AND HOSPITAL-LEVEL VARIATION IN ORAL ANTICOAGULANT USE FOR STROKE PREVENTION IN ATRIAL FIBRILLATION. Journal of the American College of Cardiology. Elsevier BV; 2018. p. A280–A280.